Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Ingrid Schütz-Fuhrmann"'
Autor:
Katharina Secco, Petra Martina Baumann, Tina Pöttler, Felix Aberer, Monika Cigler, Hesham Elsayed, Clemens Martin Harer, Raimund Weitgasser, Ingrid Schütz-Fuhrmann, Julia Katharina Mader
Publikováno v:
Sensors, Vol 24, Iss 14, p 4514 (2024)
Objective: The aim of this analysis was to assess glycemic control before and during the coronavirus disease (COVID-19) pandemic. Methods: Data from 64 (main analysis) and 80 (sensitivity analysis) people with type 1 diabetes (T1D) using intermittent
Externí odkaz:
https://doaj.org/article/f262e74774b6402a9f5fb5d14a8f7804
Autor:
Andreas Melmer, Irina Zürrer, Florian Kopp, Martin Pfeifer, Erna Kamml, Gabriele Götz, Sabine Hofer, Ingrid Schütz-Fuhrmann, Andreas Hungele, Reinhard W. Holl
Publikováno v:
Swiss Medical Weekly, Vol 151, Iss 3940 (2021)
The menstrual cycle increases insulin requirements in a subset of women with type 1 diabetes as a result of reduced insulin action through sexual hormones. If exposure to sexual hormones declines during the menopause, adaptions of insulin dosing may
Externí odkaz:
https://doaj.org/article/01dd285719114e7e99bf66f07cdfb037
Autor:
Markus Laimer, Andreas Melmer, Julia K Mader, Ingrid Schütz-Fuhrmann, Heide-Rose Engels, Gabriele Götz, Martin Pfeifer, Julia M Hermann, Christoph Stettler, Reinhard W Holl
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150604 (2016)
BACKGROUND:Traditionally, basal rate profiles in continuous subcutaneous insulin infusion therapy are individually adapted to cover expected insulin requirements. However, whether this approach is indeed superior to a more constant BR profile has not
Externí odkaz:
https://doaj.org/article/96b12205a4314af1b68a5f6662a77364
Autor:
Ingrid Schütz-Fuhrmann, Birgit Rami-Merhar, Elke Fröhlich-Reiterer, Sabine E. Hofer, Martin Tauschmann, Julia K. Mader, Michael Resl, Alexandra Kautzky-Willer, Yvonne Winhofer-Stöckl, Markus Laimer, Sandra Zlamal-Fortunat, Raimund Weitgasser
Publikováno v:
Wiener klinische Wochenschrift. 135:53-61
ZusammenfassungDiese Leitlinie repräsentiert die Empfehlungen der Österreichischen Diabetes Gesellschaft (ÖDG) zur Nutzung von Diabetes-Technologie (Insulinpumpentherapie; kontinuierliche Glukosemesssysteme, CGM; Hybrid Closed Loop Systeme, HCL; A
Publikováno v:
Journal für Klinische Endokrinologie und Stoffwechsel. 16:17-25
Autor:
Ingrid Schütz-Fuhrmann
Publikováno v:
Die Diabetologie. 18:884-888
Publikováno v:
Die Diabetologie. 18:851-852
Publikováno v:
Diabetes technologytherapeutics. 24(3)
Autor:
Sandra Zlamal-Fortunat, Ingrid Schütz-Fuhrmann, Birgit Rami-Merhar, Elke Fröhlich-Reiterer, Michael Resl, Sabine E. Hofer, Marietta Stadler, Julia K. Mader, Raimund Weitgasser, Martin Bischof, Alexandra Kautzky-Willer
Publikováno v:
Wiener klinische Wochenschrift. 131:47-53
This position statement is based on current evidence available on the safety and benefits of continuous subcutaneous insulin infusion therapy (CSII, pump therapy) in diabetes with an emphasis on the effects of CSII on glycemic control, hypoglycaemia
Autor:
Martin Bischof, Sabine E. Hofer, Julia K. Mader, Ingrid Schütz-Fuhrmann, Elke Fröhlich-Reiterer, Sandra Zlamal-Fortunat, Raimund Weitgasser, Birgit Rami-Merhar, Markus Laimer, Marietta Stadler
Publikováno v:
Wiener klinische Wochenschrift. 131:119-123
This position statement represents the recommendations of the Austrian Diabetes Association regarding the clinical diagnostic and therapeutic application, safety and benefits of continuous subcutaneous glucose monitoring systems in patients with diab